A High Productivity CHO Expression System for Continuous Antibody Manufacturing

Biopharmaceuticals such as monoclonal antibodies, bi-specific antibodies and Fc-fusion proteins are becoming increasingly important as therapeutics for a wide range of diseases. However, global accessibility to these therapies remains limited due to high manufacturing costs and stringent regulatory guidelines. In order to expand access to biologics, highly productive, cost efficient cell lines are essential. Integrated, continuous manufacturing systems for cell expression systems can help lower cost of goods manufactured while still delivering exceptionally high-quality products. Watch this webinar to discover: A 75% reduction in industry standard cost of goods manufactured How to achieve exceptionally high antibody titers High-quality cell lines and reagents for optimal performance